Nutex Health (NUTX) Tops Q2 EPS by 450c

Nutex Health (NASDAQ: NUTX) reported Q2 EPS of $9.38, $4.50 better than the analyst estimate of $4.88. Revenue for the quarter came in at $210.75 million versus the consensus estimate of $214.99 million.

For earnings history and earnings-related data on Nutex Health (NUTX) click here.

You May Also Be Interested In

• Wolfe Research Upgrades Abbvie (ABBV) to Outperform
• Active options: Popular stocks with increasing option volume: NVDA TSLA SPCX MU AAPL INTC CRWV
• Sea Ltd. (SE) PT Raised to $153 at Morgan Stanley